Skip to content
STAT: psychedelics· Meghana Keshavan·AI score42

Compass Pathways CEO Kabir Nath says company will go slow before going fast on COMP360 launch

Compass Pathways CEO: Psychedelics company will ‘go slow before we go fast’

AI summary

Compass Pathways chief executive Kabir Nath said the company will "go slow before we go fast" as it prepares to complete a rolling FDAThe Food and Drug Administration, the United States regulator of medicines, medical devices and food.Open the glossary submission this quarter for COMP360.

Key facts

Compound
Psilocybin
Condition
Depression
Organisation
Compass Pathways
Jurisdiction
United States
Source
STAT: psychedelics (statnews.com)
Published
How this summary was made

The summary was written by an AI model from the linked source, and a model scored the item against this site's editorial criteria. The facts above come from the item's topics and from identifiers written out in the stored text. Anything not found there is left out, so a missing row means not stated, not no. Read the original before relying on any detail. Editorial method

Source: STAT: psychedelics · statnews.com

Connected to

Compound
Psilocybin
Condition
Depression
Organisation
Compass Pathways
Jurisdiction
United States

Other recent items on these topics